High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)
Files
Publication date
2018-08-01
Authors
Bonekamp, Nadia
Caorsi, Roberta
Viglizzo, Gian Maria
de Graaf, M
Minoia, Francesca
Grossi, Alice
Picco, Paolo
Ceccherini, Isabella
Frenkel, Joost
Gattorno, Marco
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Fever Syndromes, Inflammation, Treatment, Taverne, General Biochemistry,Genetics and Molecular Biology, Immunology and Allergy, Rheumatology, Immunology, Letter
Citation
Bonekamp, N, Caorsi, R, Viglizzo, G M, Graaf, M D, Minoia, F, Grossi, A, Picco, P, Ceccherini, I, Frenkel, J & Gattorno, M 2018, 'High-dose ustekinumab for severe childhood deficiency of interleukin-36 receptor antagonist (DITRA)', Annals of the Rheumatic Diseases, vol. 77, no. 8, pp. 1241-1243. https://doi.org/10.1136/annrheumdis-2017-211805